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Summary  25	
 26	
Viral respiratory infections continue to pose a major global healthcare burden. At the 27	
community level, the co-circulation of respiratory viruses is common and yet studies 28	
generally focus on single aetiologies. We conducted the first comprehensive 29	
epidemiological analysis that encompasses all major respiratory viruses in a single 30	
population. Using extensive multiplex PCR diagnostic data generated by the largest 31	
NHS board in Scotland, we analysed 44,230 patient episodes of respiratory illness that 32	
were simultaneously tested for eleven virus groups between 2005 and 2013, spanning 33	
the 2009 influenza A pandemic. We measured viral infection prevalence, described co-34	
infections, and identified factors independently associated with viral infection using 35	
multivariable logistic regression. Our study provides baseline measures and reveals new 36	
insights that will direct future research into the epidemiological consequences of virus 37	
co-circulation. In particular, our study shows that (i) human Coronavirus infections are 38	
more common during influenza seasons and in co-infections than previously recognised, 39	
(ii) factors associated with co-infection differ from those associated with viral infection 40	
overall, (iii) virus prevalence has increased over time especially in infants <1, and (iv) 41	
viral infection risk is greater in the post-2009 pandemic era, likely reflecting a 42	
widespread change in the viral population that warrants further investigation.  43	
 44	
 45	
 46	
 47	
 48	
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Main text  49	
 50	
Introduction 51	
 52	
Acute respiratory infections are the commonest cause of illness in all ages, and a 53	
leading cause of mortality in children under five, creating a significant global healthcare 54	
burden [1-3]. Various aetiological pathogens (viruses, bacteria and some fungi) are 55	
recognised, causing largely indistinguishable symptoms. In most settings, viruses are 56	
the most frequently detected agent [4, 5]. Although most infections are mild, respiratory 57	
viruses have the potential to cause severe illness in high risk groups.  58	
 59	
Although influenza is a major research focus [6], the advent of PCR technology has led 60	
to improved awareness that non-influenza viruses are also important contributors to 61	
disease burden, and of the role of viral subtype in clinical severity [7-9]. The use of PCR 62	
testing as part of routine diagnostics provides an important resource for monitoring 63	
respiratory viruses as part of national surveillance [10].  64	
  65	
Multiplex PCR methods in particular provide a valuable resource for epidemiological 66	
enquiry [11]. All patients requiring microbiological diagnosis are tested for all pathogens 67	
included in the panel, ensuring consistency in testing across patients. The collation of 68	
multiplex diagnostic data from a large patient population and over an extended 69	
timeframe therefore enables robust comparisons of infection trends temporally and 70	
across patient subgroups. Furthermore, when testing is implemented over multiple 71	
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years, sufficient data can be accrued to investigate the clinical relevance of co-infections 72	
and their epidemiological patterns [12]. 73	
 74	
Although the utility of diagnostic data in the epidemiology of respiratory infections has 75	
been demonstrated [11, 13-16], studies that cover all major viruses, patient age and 76	
illness severity groups, and that span multiple years, are lacking. The largest NHS 77	
health board in Scotland, Greater Glasgow and Clyde (NHSGGC), has used multiplex 78	
PCR testing as part of their routine diagnostic services since 2005. This health board 79	
serves ~1.1 million people, representing ~1.7% of the total UK population [17]. The 80	
resultant accumulation of data provides a novel opportunity to investigate viral 81	
respiratory infections in a more comprehensive fashion than previously possible. These 82	
data also provide a unique opportunity to compare the periods before and after the 83	
introduction of the novel pandemic influenza virus (A(H1N1)pdm09) into Scotland [see 84	
18]. 85	
 86	
We analysed diagnostic data generated by NHSGGC using multiplex PCR from 2005 to 87	
2013 with the objectives to (i) describe testing and virus prevalence trends, (ii) examine 88	
temporal and patient subgroup distributions for each individual virus, and (iii) compare 89	
factors associated with overall viral infection and co-infection using statistical modelling, 90	
in order to provide robust and timely estimates of who is most at risk of viral-associated 91	
respiratory illness, and when, within a major urban UK population.  92	
 93	
Methods 94	
 95	
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Virological data 96	
In this study we used virological diagnostic data generated by the West of Scotland 97	
Specialist Virology Centre (WoSSVC) for NHSGGC during 2005 to 2013 [19]. During this 98	
period, a total of 61,427 clinical samples were received from 40,962 patients attending 99	
primary and secondary healthcare services for respiratory diagnostic purposes (i.e. 100	
excluding pathology-origin samples). The large majority of clinical samples (98%) were 101	
taken from the upper or lower respiratory tract: primarily nasal and/or throat swabs 102	
(67%), gargles (13%), nasopharyngeal aspirates (7%), sputum (5%), bronchoalveolar 103	
lavage (3%) and nasopharyngeal/endotracheal secretions (2%). In a minority of cases 104	
(n=142 samples), plasma was additionally taken for follow-up investigation; most of 105	
these samples (89%) related to the 2009 influenza A pandemic period which was 106	
excluded from statistical modelling analyses. 107	
 108	
Each sample was tested by real-time RT-PCR for eleven groups of respiratory viruses: 109	
human Rhinovirus (RV); Influenza A virus (IAV; a generic assay detecting seasonal 110	
H3N2 and H1N1 subtypes and one specific to A(H1N1)pdm09), Influenza B virus (IBV), 111	
human Respiratory syncytial virus (RSV), human Coronavirus (CoV; aggregating 229E, 112	
NL63, HKU1 and OC43 species), Adenovirus (AdV), human Metapneumovirus (MPV) 113	
and human Parainfluenza types 1-4 (PIV1-4). Details of nucleic acid extraction methods 114	
and the real-time PCR assays are provided elsewhere [20].  115	
 116	
Complete testing coverage across viruses was largely maintained throughout the study 117	
period. However, high frequencies of partial testing did arise due to the burden placed 118	
on laboratory resources during the major waves of A(H1N1)pdm09 virus circulation. The 119	
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laboratory protocols were consistent throughout the study period, with the exception of 120	
the RV assay which was modified during 2009 to detect a wider array of RV and 121	
enteroviruses (including D68), and the CoV-HKU1 assay which was discontinued in 122	
2012. 123	
 124	
Data preparation and descriptive analysis 125	
For each of the 61,427 clinical samples, positive/negative PCR test results were 126	
recorded by the laboratory for each virus group. Information was also provided on the 127	
sampling date, patient age at sampling, gender, and the origin of the sample (whether 128	
the patient had attended a General Practice (GP), hospital outpatient or non-critical care 129	
inpatient services, or was admitted to a critical care ward). In the case of 130	
inconclusive/absent test results or other patient information, the corresponding data 131	
were coded as missing. All patient identifiers were anonymised.  132	
 133	
Of the 40,962 patients, 8394 had multiple samples submitted for virological testing 134	
during the study period (range=1-37 samples, median=1, SD=1.22). For 70% of these 135	
patients, the samples were received within a 30-day window. We aggregated the PCR-136	
test results to within this timeframe generating single “episodes” of respiratory illness, 137	
using the collection date of the first sample when assigning temporal information. 138	
Episodes were classified as positive for a given virus if at least one sample tested 139	
positive. Following data exclusions, 44,230 patient episodes, representing 36,157 140	
individual patients, were retained for analysis of temporal distributions. We conducted 141	
descriptive statistical analyses of viral infection prevalence among the patient population 142	
providing time and age-stratified estimates. 143	
7	
	
 144	
By the end of April 2009, Scotland was afflicted by the influenza pandemic [20]. Figure 145	
1a highlights the resultant upsurge in testing frequencies during the summer and autumn 146	
waves of 2009, and during a third wave of A(H1N1)pdm09 virus circulation in the winter 147	
of 2010/11. During these periods, testing was primarily directed towards IAV and only 148	
subsets of IAV-negative patients were tested for other viruses. Due to this disruption in 149	
regular testing procedures, we focused our description of viral infection distributions 150	
across patient subgroups on the 26,974 patient episodes tested out with this period, and 151	
refer readers to a previous report for details of viruses detected during the 2009 152	
pandemic [20].  153	
 154	
Co-infection analyses 155	
For each virus group, we compared the frequency of mono-infection episodes (one virus 156	
group detected) and co-infection episodes (more than one virus group detected). To 157	
correctly classify episodes into these subgroups, we excluded all partially tested 158	
patients. In more detailed analyses, we counted the frequency of each possible virus 159	
pair and quantified the statistical correlation between mono-infection and co-infection 160	
frequencies across viruses.  161	
 162	
Statistical associations 163	
We investigated statistical associations between time period, season, patient age, 164	
gender, and GP/general hospital/critical care origin (a proxy for illness severity), and two 165	
outcomes: (i) virus-positive versus virus-negative episodes, and (ii) co-infection versus 166	
mono-infection episodes. With respect to time, we split sampling dates into two major 167	
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periods either side of the influenza pandemic and periods of high partial testing: pre-168	
pandemic (prior to May 2009 when the A(H1N1)pdm09 virus was established in 169	
Scotland) and post-pandemic (following subsidence of the third major wave of the 170	
A(H1N1)pdm09 virus in January 2011).  171	
 172	
Associations with each factor were first assessed by crude unadjusted odds ratios, and 173	
then adjusted for confounding using multivariable logistic regression models that 174	
included all factors to assess their independence. Statistical interactions were examined 175	
using Mantel-Haenszel (MH) stratification methods (based on a p-value <0.05, results 176	
not shown). The potential interactions were added to the main effects models and their 177	
significance assessed based on an interaction parameter p-value <0.05. Model fit was 178	
assessed by le Cessie van Houwelingen global goodness of fit tests [21]. All statistical 179	
analyses were carried out in R v.3.1.1 [22]. 180	
 181	
To correctly classify patients into outcome groups, all partially tested patients were 182	
excluded. Of the 36,157 fully tested patients, 90% sought healthcare facilities once 183	
during the study period thereby contributing a single episode. However, 4218 patients 184	
had attended healthcare facilities more than once, providing information for multiple 185	
episodes (range 2-26 episodes; median=2; SD=2.04). We retained the first observed 186	
episode per patient in the statistical analyses to ensure the patient-level interpretation of 187	
statistical associations was not influenced by the non-independence of data relating to 188	
the same individual. See supplementary Figure S1 for full details of data preparation. 189	
 190	
Results 191	
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 192	
Episodes of illness and viral infection frequencies 193	
We analysed 44,230 episodes of respiratory illness tested by WoSSVC during 2005 to 194	
2013. Full details of patient distributions across subgroups and per study year are 195	
provided in supplementary Table S1. The median patient age was 27 years (range=0-98 196	
years, SD=25.5 years) and 49% were male. Excluding the three major waves of 197	
Influenza A(H1N1)pdm09 virus circulation, episode frequencies increased year-by-year 198	
from 2472 cases tested in 2005 to 6149 cases tested in 2013. However, the age 199	
patterns were not consistent over this period; the percentage of adult episodes was 200	
greater in 2013 than in 2005 (e.g. 21% vs. 8% in patients aged ≥65 years), whilst the 201	
percentage of child episodes was less in 2013 than 2005 (e.g. 16% vs. 26% in patients 202	
aged 1-5 years) (Figure 1b).  203	
  204	
At least one virus was detected in 35% (15,302/44,230) of tested patients; these patients 205	
had a median age of 17 years (range=0-96 years, SD=25 years) and 49% were male. 206	
The prevalence of confirmed viral infection among the patient population was greater in 207	
the 2013 influenza season than in 2005 among all age groups (Figure 1c); the absolute 208	
difference in prevalences were 22% (infants <1 year old), 12% (1-5 year olds), 14% (6-209	
16 year olds), 18% (17-45 year olds), 12% (46-64 year olds) and 17% (≥65 year olds). 210	
Overall virus-specific prevalences among the patient population were ranked as follows: 211	
RV (14%, n=4847); IAV (9.7%, n=4244); RSV (4.9%, n=1786); CoV (4.1%, n=1339); 212	
AdV (3.6%, n=1221); IBV (3%, n=1019); MPV (2.6%, n=345); PIV-3 (2.2%, n=757); PIV-213	
4 (0.86%, n=286) ; PIV-1 (0.84%, n=295) and PIV-2 (0.35%, n=122). Age distributions 214	
for each viral infection group are presented in supplementary Table S2. The most 215	
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common infection in each six-month period (excluding 2009) was RV, constituting a low 216	
of 19% of infections during the typical influenza period of 2005/06, to a high of 59% 217	
during the typical non-influenza period of 2010 (Figure 1d).  218	
 219	
For most virus groups, detections were most frequent in 1-5 year olds (with the 220	
exception of IAV, IBV and CoV), males, and hospital-attendees not admitted to a critical 221	
care ward (Figure 2). Seasonally, virus detections were most common in December 222	
(45% among GP-attendees and 43% among hospital-attendees) and least common in 223	
August (11% among GP-attendees and 22% among hospital-attendees) (Figure 3a,c). 224	
The most commonly detected viral infection in each month was RV, peaking in 225	
September among both GP and hospital-attendees (Figure 3b,d). Influenza A and B 226	
were the most common detections in December-March among GP-attendees (combined 227	
proportion ranging 31% - 45%), and in January-February among hospital-attendees 228	
(combined proportion of 30%). Of the remaining non-influenza viral infections, a large 229	
proportion was attributed to RSV, RV and CoV during periods of high influenza activity; 230	
their combined proportions ranged 39% - 52% among GP attendees (December-March) 231	
and 51% - 55% among hospital-attendees (January-February).  232	
 233	
Of 9094 positive patients (among 26,974 patients out with the pandemic period), 1952 234	
were GP-attendees, 6560 were general hospital-attendees (outpatients and non-critical 235	
care inpatients), and 1282 were inpatients admitted to a critical care ward (an intensive 236	
care unit (ICU), intensive therapy unit (ITU), high dependency unit (HDU), or coronary 237	
care unit (CCU)). The latter group provided a proxy for classifying episodes of severe 238	
respiratory illness. Eighty-eight percent (n=4443) of GP-attendees and 69% (n=15,027) 239	
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of hospital-attendees were over 5 years of age. As shown in Figure 4, the prevalence of 240	
severe episodes among all virus-positive patients, regardless of origin, was greater 241	
among patients with RV (7.5%), RSV (7.5%), PIV1 (11.8%) and PIV4 (7.4%) infections 242	
than among virus-negative patients or other viral infections including IAV (5.5%) and IBV 243	
(4.1%). Investigating further the RV/ IAV and RV/PIV1 comparisons, we found the 244	
observed difference in prevalence was statistically significant based on Pearson’s Chi 245	
squared tests (p=0.036 and p=0.05 respectively). Age-specific prevalence of severe 246	
episodes was greatest at the extremes of age (under-fives and adults over 65) for all 247	
viruses except hPIV2 (we note the particularly small sample size for this virus group).  248	
 249	
Co-infections and virus mixing patterns 250	
Of 9654 virus-positive patients, among 27,284 episodes tested for all eleven viruses, 251	
11% (1086/9654) had a co-infection. The median age among co-infected patients was 252	
three years (range=0-91 years, SD=22 years) and 58% were male. Co-infections were 253	
more commonly detected among under-fives overall (18% compared to 7% among over 254	
fives) and for each viral infection, particularly RV, RSV, AdV and CoV (detected in 6%, 255	
3%, 3% and 2% of these infections respectively in under-fives) (Figures 5a-b).  256	
 257	
A total of 1389 virus pairs were detected among 1086 episodes of co-infection; most 258	
episodes involved two viruses (87%; 964/1086), the remaining involved three (n=105), 259	
four (n=15) and five (n=2) viruses. All viruses were detected with most others at least 260	
once (Figure 5c); however, a clustering pattern was evident in which RV, AdV, RSV and 261	
CoV were frequently detected with one another. The most common virus detection in a 262	
co-infection was RV (56% of co-infections), the majority of which were with AdV (n=195, 263	
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25%) and RSV (n=181, 23%). Other viruses relatively frequently detected in co-264	
infections were AdV, RSV and CoV; constituting 31%, 30% and 28% of co-infections 265	
respectively. 266	
 267	
We found a significant positive correlation between virus detection frequencies in mono-268	
infections and co-infections; Pearson’s product-moment correlation = 0.88 (95% CI = 269	
0.60 - 0.97, p<0.001) and fitted linear regression model slope = 0.85, p<0.001 (Figure 270	
5d). However, IAV and IBV were identified in co-infections at relatively low frequencies 271	
(n=121 and n=68 respectively) compared to non-influenza viruses (e.g. RV, n=678) 272	
(Figure 5d). 273	
 274	
Factors associated with viral infection and co-infection 275	
Table 1 summarises the results of univariable and multivariable logistic regression 276	
analyses for associations with viral infection. Season, age group, and patient origin were 277	
significantly associated with the odds of viral infection based on unadjusted odds ratio 278	
estimates. In the multivariable analysis, several independently significant factors were 279	
identified based on the adjusted odds ratios. Viral respiratory infections were more likely 280	
detected in winter, in children aged 1-5 years, and among GP-attendees, irrespective of 281	
the other factors. Following adjustment for multiple factors, time period was also a 282	
significant predictor (because of a negative confounding by age): the odds of viral 283	
infection were significantly greater post-pandemic than pre-pandemic. 284	
 285	
Significant statistical interactions (based on p<0.05) revealed that the effect of age was 286	
not homogeneous across gender or patient origin subgroups. This variation in age 287	
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association across other factors is shown in Figure 6a-b where age-specific infection 288	
prevalences are stratified by the third factor. These figures show that the age distribution 289	
of infection differed according to gender and patient origin subgroups. 290	
 291	
Table 2 summarises the results of univariable and multivariable logistic regression 292	
analyses for associations with co-infection. Several differences were found in 293	
comparison with viral infections overall. Based on unadjusted odds ratio estimates, time 294	
period, season (autumn only), age group, gender and patient origin were significantly 295	
associated with co-infection. However, in the multivariable analysis time period and 296	
gender were confounded by age and were therefore not identified as significant 297	
independent factors. In contrast to viral infection overall, co-infections were equally likely 298	
to be detected in spring and winter, were less likely detected among 1-5 year olds than 299	
infants, and were more likely detected among general hospital-attendees (outpatients 300	
and those not admitted to critical care wards) than GP-attendees. 301	
 302	
Significant statistical interactions (based on p<0.05) revealed that the effect of age on 303	
co-infection status was not homogeneous across gender and patient origin groups. In 304	
contrast to viral infection overall, co-infections were relatively more common in males 305	
than females among 46-64 year olds and among hospital-attendees in all age groups 306	
(Figures 6c-d).  307	
 308	
There was no evidence of a poor model fit based on the global goodness of fit tests: (i) 309	
p-values=0.147, 0.07, 0.07 for the main effect model and two models with interaction 310	
terms respectively for associations with viral infection overall, and (ii) p-values=0.940, 311	
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0.985, 0.746 for the main effect model and two models with interaction terms 312	
respectively for associations with co-infection. 313	
 314	
Discussion 315	
 316	
The advent of multiplex-PCR as part of routine diagnostics provides an unprecedented 317	
opportunity for studying the epidemiology of multiple respiratory viruses simultaneously 318	
within a single population. Previous UK-based studies have highlighted the utility of 319	
laboratory-based surveillance for monitoring respiratory infection trends, and in 320	
comparing the relative burdens between viruses [10, 13, 23]. Our study is the first to 321	
compare the epidemiologies of different respiratory virus groups utilising extensive 322	
diagnostic data generated by multiplex RT-PCR from patients attending both primary 323	
and secondary healthcare services.  324	
 325	
The collation of test negative results by diagnostic laboratories provides valuable 326	
denominator information for measuring disease occurrence, to estimate the relative 327	
contribution of different pathogens to healthcare usage (such as GP consultations) and 328	
to provide an early warning for periods of increased healthcare pressures. Importantly, 329	
the diagnostic test data utilised in this study were generated by a single laboratory, 330	
permitting a more consistent comparison of trends across patient and virus groups 331	
because testing methods were on the whole standardised throughout the study. 332	
 333	
Our study has revealed changes in the frequency of virological testing of respiratory 334	
illnesses in the NHSGGC health board during 2005 to 2013, with adults representing an 335	
15	
	
increasingly greater percentage of episodes. However, age-specific prevalences were 336	
greater in the 2013 influenza season than in 2005 for all age groups. It is possible that 337	
there is raised awareness among the public and/or clinicians, and consequently greater 338	
healthcare seeking and/or sampling behaviour in adults. Alternatively these results could 339	
reflect a true increase in non-viral causes of respiratory illness among this age group. 340	
We note that a shift in the demography of the Glasgow population has been reported 341	
[24]. Our observations might indicate the impact of an aging population on respiratory-342	
related healthcare services, through an increase in GP/hospital consultations, or a 343	
genuine increase in the incidence of adult respiratory infections.  344	
 345	
Rhinovirus was the most prevalent virus overall, corroborating previous UK-based 346	
studies that include patients attending both primary and secondary healthcare services 347	
[10, 12]. The clinical significance of RV is disputed, although severe cases of disease 348	
are recognised depending on virus species, patient subgroups, and season [7, 25-27]. In 349	
additional analyses (Figure 4) we found the prevalence of severe respiratory illness 350	
(patients located in critical care wards) was significantly greater among RV infections 351	
than IAV, supporting the proposition that RV is associated with more severe disease 352	
than traditionally accepted.  353	
 354	
Of the other non-influenza viruses, RSV and CoV were relatively highly prevalent. We 355	
note that the extent of research into the commonly circulating coronaviruses is small 356	
when compared to IAV and RSV, although severe clinical cases are recognised [28]. 357	
Our study is the first comparative analysis in the UK to include CoV, providing an 358	
important opportunity to quantify its temporal and patient subgroup distributions and co-359	
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infection patterns in comparison to the other common virus groups. We confirm that CoV 360	
contributes a large fraction of infections during periods of high influenza activity and that 361	
CoV is relatively frequently co-detected with other viruses. The contribution of different 362	
respiratory viruses to the healthcare burden in Scotland has previously been studied 363	
[23]. Further investigation on a seasonal basis is needed to help elucidate the public 364	
health relevance of RV and CoV, particularly since CoV has a similar age distribution as 365	
the influenza viruses. The remaining viruses (AdV, MPV, and PIV1-4) were detected in 366	
comparatively smaller numbers on a yearly basis and during months of high influenza 367	
activity. 368	
 369	
The nine-year study period provided a novel opportunity to compare the epidemiology of 370	
respiratory viruses before and after the 2009 influenza A pandemic [18]. In our 371	
multivariable statistical analysis we found viral infections to be more likely in the post-372	
pandemic era. This result was independent of other factors such as patient age implying 373	
non-patient factors, such as a change in the underlying virus population, have increased 374	
the likelihood that a patient seeking healthcare services will have a viral infection (as 375	
opposed to non-viral causes). Whether this is a direct consequence of the pandemic 376	
virus, its impact on the epidemiologies of others viruses, or a consequence of long-term 377	
changes in the non-influenza virus population, remains to be elucidated. Seasonal and 378	
patient-related factors corroborate existing knowledge and were independent of time, 379	
indicating the generality of these factors as predictors of viral infection. 380	
 381	
It is well recognised that the burden of viral respiratory illness lies predominantly among 382	
young children [29]. We found that among patients with respiratory illness attending 383	
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healthcare facilities, 1-5 year olds were more likely than other age groups to have a viral 384	
infection independent of season or time period. The most commonly detected viruses 385	
among this age group were RV, RSV, AdV and MPV (20%, 9.3%, 9.1% and 4.7% of 386	
infections respectively) corroborating previous reports [23, 30]. Together with a recent 387	
study that found bacterial-viral co-infections were relatively uncommon in children with 388	
pneumonia [31], these findings support the concern regarding the over-prescription of 389	
antibiotics in children [32]. That the increasing trend in virus prevalence was most 390	
notable among infants (<1 year) also warrants further attention. Whilst it is possible that 391	
these findings are influenced by changes in clinical testing decisions, we note that this 392	
trend is particularly pertinent in relation to recent European outbreaks of enterovirus D68 393	
in children [33]; investigation into the contribution of individual viruses will be the focus of 394	
future work. We further note that, based on the multivariable statistical analyses, the 395	
increasing trend in prevalence among children explained why co-infections were more 396	
likely detected in the post-2009 pandemic era. 397	
 398	
There are very few studies describing co-infection patterns among respiratory viruses. 399	
Our study provides the largest examination to date, confirming that around 11% of viral 400	
infections among patients attending healthcare services in an urban setting involve more 401	
than one virus, similar to the 10.4% reported by a previous UK-based study [12]. That 402	
nearly all respiratory viruses were co-detected with all others highlights the sufficient 403	
opportunities for co-infections. We would expect co-infection frequencies to reflect 404	
individual virus prevalences. Indeed, in line with the aforementioned study [12], RV was 405	
the most common detection among co-infections, RV/RSV was a frequent pairing, and 406	
most co-infections were in children under five. Our study also reveals that CoV are 407	
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relatively frequently involved in co-infections. However, co-infections with influenza 408	
viruses were relatively few, perhaps explained by differences in their age and seasonal 409	
distributions, or an inter-viral interference [34]. 410	
 411	
We found that the average age of co-infection was three years, compared to 17 years 412	
for viral infections overall, and co-infections were more likely in infants than 1-5 year 413	
olds. That co-infections were more likely in young children is likely explained by (i) a 414	
greater opportunity for co-infection due to a shorter exposure lifetime and consequently 415	
greater susceptibility to a wider array of viruses, and (ii) a greater chance of co-416	
infections being detected because children tend to shed virus for longer periods.  417	
 418	
In adults, the age distribution of co-infections differed according to gender and patient 419	
origin; the prevalence was greatest in males and among general hospital-attendees not 420	
admitted to critical care wards in 46-64 year olds (Figure 6c-d). This result provides 421	
insight into an age-dependent factor in co-infection patterns among adults but must be 422	
viewed with some caution; it is potentially influenced by a bias in multiple specimens 423	
submitted in relation to single episodes of illness among adults, most likely as a result of 424	
co-morbidities. Interestingly, co-infections were more likely among general hospital-425	
attendees not admitted to critical care wards than GP-attendees, supporting the potential 426	
role of co-infections in illness severity [35].   427	
 428	
There are several limitations to our study to be noted. Detection of viral nucleic acid may 429	
not represent active infection for all viruses in all cases [36], potentially introducing 430	
detection biases temporally and across patient groups. Furthermore, the timing of 431	
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infection events, and variation in shedding duration across virus and patient groups [37, 432	
38], could potentially bias the observed co-infection patterns. We also note that our 433	
study lacked information on the presence/absence of bacterial pathogens which are also 434	
significant contributors to respiratory infections.  435	
 436	
One further important consideration is that laboratory diagnostic data cannot inform on 437	
the epidemiology of asymptomatic infections in the community, or among symptomatic 438	
people who do not attend healthcare services. Furthermore, that viral populations are 439	
not static could also impact on the generalisability of the observed trends and 440	
associations; the introduction of new strains can alter disease outcomes, and 441	
consequently healthcare seeking behaviour, influencing the stability of healthcare 442	
consultation rates among patient subgroups. Given the dynamic nature of virus 443	
populations, the epidemiological information generated through surveillance must be 444	
maintained to ensure future vaccine and antiviral developments are directed to where 445	
they are most needed [39, 40].  446	
 447	
Conclusions 448	
Our study provides the most comprehensive description of viral respiratory infections in 449	
the UK to date, revealing new epidemiological insights with public health relevance. Of 450	
particular concern is a greater viral prevalence in 2013 compared with 2005, particularly 451	
in infants, and a greater risk of viral infection in the post-2009 pandemic era. Further 452	
investigation into the long-term temporal dynamics of individual viruses and the 453	
epidemiological consequences of virus co-circulation is needed.  454	
 455	
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Figure legends 578	
 579	
Figure 1. Trends in episodes of respiratory illness and viral infection prevalence 580	
among patients seeking healthcare services within NHS Greater Glasgow and 581	
Clyde during 2005 to 2013. 582	
(a) Episodes of respiratory illness tested in each month highlighting the three major 583	
waves of A(H1N1)pdm09 virus circulation; (b) Distribution of episodes across age 584	
groups in each six-month period; (c) Age-specific prevalence of confirned viral infection 585	
and virus-negative illness detected in each six-month period; (d) Relative prevalence of 586	
each viral infection and virus-negative illness (Neg*) in each six-month period; (A) = 587	
typical non-influenza period (April-September) and (B) = typical influenza period 588	
(October-March). Note that January-March 2005 and October-December 2013 were 589	
excluded from figure (d).  590	
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 591	
Figure 2. Episodes of viral respiratory infection by patient subgroup 592	
Distribution of each viral infection and virus-negative illness (Neg*) by (a) age group, (b) 593	
gender, and (c) patient-origin. These results are based on 26,974 patient episodes of 594	
respiratory illness; excluding patients tested during the major waves of Influenza 595	
A(H1N1)pdm09 virus circulation. GP = General Practitioners surgery, Hospital: general = 596	
outpatients and non-critical care patients; Hospital: critical care = patients admitted to an 597	
intensive care, intensive therapy, high dependency, or coronary care unit. 598	
 599	
Figure 3. Distribution of virus positive/negative episodes of illness and respiratory 600	
infection types detected in each calendar month 601	
(a,b) patients attending primary healthcare services (General Practitioners) and (c,d) 602	
patients attending secondary healthcare services (hospital inpatients and outpatients). 603	
These results are based on 26,974 patient episodes of respiratory illness; excluding 604	
patients tested during the major waves of Influenza A(H1N1)pdm09 virus circulation. 605	
 606	
Figure 4. Prevalence of severe cases among patients with confirmed viral 607	
infection attending primary and secondary healthcare facilities in NHSGGC during 608	
2005 to 2013 609	
Comparing across viral infection types and virus-negative patients (Neg*). Absolute 610	
numbers of severe cases are indicated in parentheses. Severe cases were identified 611	
27	
	
based on patient admission to intensive care, intensive therapy, high dependency or 612	
coronary care units. 613	
 614	
Figure 5. Co-infection and virus mixing patterns among patients tested for all 615	
virus groups 616	
Comparing mono-infection and co-infection distributions for each virus group among (a) 617	
children ≤ 5 years of age, and (b) patients > 5 years of age. (c) A network of co-618	
infections: each node represents a respiratory virus and links between viruses are 619	
proportional to the frequency at which each virus pair was observed among co-infected 620	
patients. Viruses are coloured according to their prevalence among co-infections 621	
(darker=greater prevalence). (d) Correlation between mono-infection and co-infection 622	
frequencies across virus groups; solid line=fitted linear regression model with 623	
corresponding R2 value. 624	
 625	
Figure 6. Stratification of viral infection and co-infection associations 626	
Age-specific viral infection (a,b) and co-infection (c,d) prevalences stratified by gender 627	
and patient origin. Significant interactions with age are indicated by *. 628	
 629	
 630	
 631	
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Table 1: Investigating factors associated with viral infection using logistic regression 632	
Factor Level Summary* Virus-positive* 
Virus-
negative* 
Unadjusted 
OR (95% CI, 
p-value)† 
Adjusted OR 
(95% CI, p-
value)‡ 
Time 
period 
Pre-
pandemic 
6296  
(39) 
2090  
(39) 
4206  
(39) 
Reference Reference 
Post-
pandemic 
9961  
(61) 
3315  
(61) 
6646  
(61) 
1.00 (0.94 – 
1.07, 
p=0.912) 
1.31 (1.22 – 
1.41, 
p<0.001) 
Season 
Winter 5016  
(31) 
2001  
(37) 
3015  
(28) 
Reference Reference 
Spring 4305  
(26) 
1541  
(29) 
2764  
(25) 
0.84 (0.77 – 
0.91, 
p<0.001) 
0.79 (0.73 – 
0.87, 
p<0.001) 
Summer 2952  
(18) 
667  
(12) 
2285  
(21) 
0.44 (0.40 – 
0.49, 
p<0.001) 
0.42 (0.38 – 
0.47, 
p<0.001) 
Autumn 3984  
(25) 
1196  
(22) 
2788  
(26) 
0.65 (0.59 – 
0.71, 
p<0.001) 
0.61 (0.56 – 
0.67, 
p<0.001) 
Age group 
(years) 
< 1 1277  
(13) 
959 
(18) 
1218 
(11) 
Reference Reference 
1-5 2596  
(16) 
1327 
(25) 
1269 
(12) 
1.33 (1.18 – 
1.49, 
p<0.001) 
1.25 (1.11 – 
1.41, 
p<0.001) 
6-16 1722  
(11) 
564 
(10) 
1158 
(11) 
0.62 (0.54 – 
0.71, 
p<0.001) 
0.53 (0.46 – 
0.60, 
p<0.001) 
17-45 3782 1035 2747 0.48 (0.43 – 
0.53, 
0.36 (0.32 – 
0.40, 
29	
	
(23) (19) (25) p<0.001) p<0.001) 
46-64 3247  
(20) 
866 
(16) 
2381 
(22) 
0.46 (0.41 – 
0.52, 
p<0.001) 
0.37 (0.33 – 
0.41, 
p<0.001) 
≥65 2733 
(17) 
654 
(12) 
2079 
(19) 
0.40 (0.35 – 
0.45, 
p<0.001) 
0.34 (0.30 – 
0.39, 
p<0.001) 
Gender 
Female 7941 
(49) 
2575 
(48) 
5366 
(49) 
Reference Reference 
Male 8316 
(51) 
5486 
(52) 
2830 
(51) 
1.07 (1.01 – 
1.15, p=0.03) 
1.08 (1.01 – 
1.15, 
p=0.032) 
Patient 
origin¥ 
 
GP 3012 
(19) 
1260 
(23) 
1752 
(16) 
Reference Reference 
Hospital: 
general 
11,878 
(73) 
3725 
(69) 
8153 
(75) 
0.64 (0.59 – 
0.69, 
p<0.001) 
0.54 (0.49 – 
0.59, 
p<0.001) 
Hospital: 
critical care 
1367 
(8) 
420 
(8) 
947 
(9) 
0.62 (0.54 – 
0.71, 
p<0.001) 
0.56 (0.49 – 
0.65, 
p<0.001) 
 633	
* Distribution of patient numbers, with corresponding % in parantheses, across factor 634	
levels for all patients (summary) and for virus-positive and virus-negative groups; † 635	
Unadjusted odds ratios (OR) based on univariable logistic regression; ‡ Adjusted OR 636	
based on multivariable logistic regression; ¥ Patient location corresponding with first 637	
clinical sample: GP = General Practitioners surgery, Hospital: general = outpatients and 638	
non-critical care patients; Hospital: critical care = patients admitted to an intensive care, 639	
intensive therapy, high dependency, or coronary care unit. 640	
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Table 2: Investigating factors associated with co-infection using logistic regression 641	
Factor Level Summary* Co-infection* 
 Mono-
infection* 
Unadjusted 
OR (95% CI, 
p-value) † 
Adjusted OR 
(95% CI, p-
value) ‡ 
Time 
period 
Pre-
pandemic 
2090  
(39) 
232 
(44) 
1858 
(38) 
Reference Reference 
Post-
pandemic 
3315  
(61) 
293 
(56) 
3022 
(62) 
0.78 (0.65 – 
0.93, 
p=0.006) 
0.97 (0.80 – 
1.18, 
p=0.774) 
Season 
Winter 2001 
(37) 
209 
(40) 
1792 
(37) 
Reference Reference 
Spring 1541 
(29) 
165 
(31) 
1376 
(28) 
1.03 (0.83 – 
1.28, 
p=0.801) 
0.94 (0.75 – 
1.18, 
p=0.595) 
Summer 667 
(12) 
54 
(10) 
613 
(13) 
0.76 (0.55 – 
1.03, 
p=0.079) 
0.55 (0.40 – 
0.76, 
p<0.001) 
Autumn 1196 
(22) 
97 
(18) 
1099 
(23) 
0.76 (0.59 – 
0.97, p=0.03) 
0.63 (0.48 – 
0.82, 
p=0.001) 
Age group 
(years) 
< 1 959  
(18) 
184 
(35) 
775 
(16) 
Reference Reference 
1-5 1327 
(25) 
187 
(36) 
1140 
(23) 
0.69 (0.55 – 
0.86, 
p=0.001) 
0.67 (0.54 – 
0.84, 
p=0.001) 
6-16 546 
(10) 
28 
(5) 
536 
(11) 
0.22 (0.15 – 
0.33, 
p<0.001) 
0.21 (0.14 – 
0.32, 
p<0.001) 
17-45 1035 47 988 0.20 (0.14 – 
0.28, 
0.21 (0.15 – 
0.30, 
31	
	
(19) (9) (20) p<0.001) p<0.001) 
46-64 866 
(16) 
47 
(9) 
819 
(17) 
0.24 (0.17 – 
0.34, 
p<0.001) 
0.24 (0.17 – 
0.34, 
p<0.001) 
≥65 654 
(12) 
32 
(6) 
622 
(13) 
0.22 (0.15 – 
0.32, 
p<0.001) 
0.21 (0.14 – 
0.31, 
p<0.001) 
Gender 
Female 2575 
(48) 
222 
(42) 
2353 
(48) 
Reference Reference 
Male 2830 
(52) 
303 
(58) 
2527 
(52) 
1.27 (1.06 – 
1.52, p=0.01) 
1.11 (0.92 – 
1.33, 
p=0.293) 
Patient 
origin¥ 
GP 1260 
(23) 
72 
(14) 
1188 
(24) 
Reference Reference 
Hospital: 
general 
3725 
(69) 
418 
(80) 
3307 
(68) 
2.09 (1.61 – 
2.70, 
p<0.001) 
1.52 (1.15 – 
2.00, 
p=0.003) 
Hospital: 
critical care 
420 
(8) 
35 
(7) 
385 
(8) 
1.50 (0.99 – 
2.28, 
p=0.058) 
1.15 (0.75 – 
1.79, 
p=0.521) 
 642	
* Distribution of patient numbers, with corresponding % in parantheses, across factor 643	
levels for all patients (summary) and for co-infection and mono-infection groups; † 644	
Unadjusted odds ratios (OR) based on univariable logistic regression; ‡ Adjusted OR 645	
based on multivariable logistic regression; ¥ Patient location corresponding with first 646	
clinical sample: GP = General Practitioners surgery, Hospital: general = outpatients and 647	
non-critical care patients; Hospital: critical care = patients admitted to an intensive care, 648	
intensive therapy, high dependency, or coronary care unit. 649	






